Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

U.S. investors looking at global index funds might start singing the 1985 song referenced above. American stocks now account for three-quarters of the MSCI World index’s allocation. Topdown Charts’ ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Texas, on Wednesday published a 47-page report titled “The Case for Healthcare Freedom" as a roadmap to "Make American ...

According to a September 2024 data brief from the Centers for Disease Control and Prevention (CDC), 40.3 percent of U.S.

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure.

An international committee of scientists has proposed a change to the way obesity is defined and diagnosed. The goal is to ...

Is obesity a disease or a risk factor for disease? In medical circles – and outside of them – the question is contentious, ...

People are being “overdiagnosed” with obesity, leading medics have warned as they called for a “reframing” of the way the condition is diagnosed. Academics have suggested that a body mass ...